AGNC Investment Reappoints Dr. Morris Davis to Strengthen Board Governance and Expertise
- AGNC Investment appointed Dr. Morris Davis to its Board of Directors effective January 12, 2026, enhancing governance.
- Dr. Davis's expertise in housing policy is expected to strengthen AGNC's decision-making in the mortgage-backed securities market.
- The reappointment aims to align AGNC's strategies with evolving housing market demands, benefiting shareholders and stakeholders.
AGNC Investment Welcomes Back Dr. Morris Davis to Its Board of Directors
AGNC Investment Corp. (Nasdaq: AGNC) has appointed Dr. Morris Davis to its Board of Directors, effective January 12, 2026. Dr. Davis previously served on the board from May 2008 until March 2025, when he resigned to take on the role of Chief Housing Economist for the Council of Economic Advisors to the President. His return marks a significant development for AGNC, as the board now comprises ten members, including eight independent directors. This strategic move is expected to strengthen the company's governance and oversight, especially given Dr. Davis's extensive expertise in housing policy and economics.
Gary Kain, Executive Chair of AGNC's Board, expresses enthusiasm about Dr. Davis's reappointment, emphasizing the value of his insights in a rapidly evolving housing market. Dr. Davis, who holds the Paul V. Profeta Chair of Real Estate at Rutgers Business School, has a notable record as a researcher and scholar in housing markets, with his work cited over 5,400 times in leading academic journals. His deep understanding of economic trends and housing policy is seen as a critical asset for AGNC, particularly as the company navigates the complexities of the residential mortgage-backed securities (Agency MBS) market.
AGNC Investment specializes in investing in Agency MBS, which are protected against credit losses by government-sponsored enterprises like Fannie Mae, Freddie Mac, and Ginnie Mae. The company's strategy involves leveraging financing through repurchase agreements and employing dynamic risk management to mitigate market risks. This approach has enabled AGNC to distribute over $15 billion in common stock dividends since its inception in 2008, establishing it as a vital source of private capital in the U.S. residential housing landscape. Dr. Davis's expertise will likely enhance the company’s decision-making processes within its Compensation and Corporate Governance Committee, further aligning AGNC's strategic objectives with the current demands of the housing market.
In other relevant developments, AGNC Investment continues to uphold its commitment to providing favorable long-term returns for shareholders through a robust investment strategy. By integrating Dr. Davis's insights into their governance framework, AGNC aims to remain agile and responsive to the ongoing changes in the economic environment and housing sector.
The reintroduction of Dr. Davis to AGNC's Board not only reinforces the company's commitment to sound governance but also positions AGNC to leverage his expertise in addressing future challenges in the housing market, ultimately benefiting its shareholders and stakeholders alike.